主營產(chǎn)品:標(biāo)準(zhǔn)品、雜質(zhì)對照品
客服熱線:18162595016; 18162595016
2YR企業(yè)會員
英文名稱 | 中文名稱 | CAS號 | 操作 |
Rasagiline Impurity 40 | 1631061-76-1 | 詳細(xì) | |
Rasagiline Impurity 41 | 4'-C-疊氮基-3'-脫氧-3'-氟胞苷 | 1145869-46-0 | 詳細(xì) |
Rasagiline Impurity 39 | 1631061-75-0 | 詳細(xì) | |
Rasagiline Impurity 36 | 1360459-39-7 | 詳細(xì) | |
Rasagiline Impurity 37 | (R)-雷沙吉蘭雜質(zhì)甲磺酸鹽 | 1360459-46-6 | 詳細(xì) |
Rasagiline Impurity 38 | 1631061-74-9 | 詳細(xì) | |
Polmacoxib Impurity 13 | 2007088-16-4 | 詳細(xì) | |
Carenoprazan Impurity 5 | 苯銹啶 | 67306-00-7 | 詳細(xì) |
Emorfazone Impurity 11 | 107741-27-5 | 詳細(xì) | |
Emorfazone Impurity 12 | 94361-21-4 | 詳細(xì) | |
Esomeprazole Impurity 179 | 107711-02-4 | 詳細(xì) | |
Ondansetron Impurity 12 | 123638-70-0 | 詳細(xì) | |
Ondansetron Hydrochloride | 96223-47-1 | 詳細(xì) | |
Emorfazone Impurity 10 | 呋嘧醇 | 56425-91-3 | 詳細(xì) |
Carenoprazan Impurity 6 | 6-[3-[[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol | 1246820-10-9 | 詳細(xì) |
Carenoprazan Impurity 7 | 38394-98-8 | 詳細(xì) | |
Carenoprazan Impurity 8 | 17Β-氰基-17Α-羥基雄甾-4-烯-3-酮 | 77881-13-1 | 詳細(xì) |
Emorfazone Impurity 5 | 214542-41-3 | 詳細(xì) | |
Emorfazone Impurity 8 | (E)-N-[(4R,4aS,7S,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide | 152658-36-1 | 詳細(xì) |
Emorfazone Impurity 2 | Naftifine (Z)-Isomer | 65473-08-7 | 詳細(xì) |
Emorfazone Impurity 3 | 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol:hydrochloride | 1164469-60-6 | 詳細(xì) |
Rasagiline Impurity 43 | 1360459-02-4 | 詳細(xì) | |
Phenylbutazone Impurity 5 Sulfate (Phenylbutazone EP Impurity E Sulfate) | AHLBNYSZXLDEJQ-HDVRVJOHSA-N | 1356930-46-5 | 詳細(xì) |
Phenylbutazone Impurity 14 | N-DEFORMYL-N-PIVALOYL ORLISTAT | 1356017-35-0 | 詳細(xì) |
Phenylbutazone Impurity 15 | N-DEFORMYL-N-BENZYLOXYCARBONYL ORLISTAT | 108051-94-1 | 詳細(xì) |
Phenylbutazone Impurity 16 | (R,S,S,S)-Orlistat Tetradecyl Ester | 1356019-45-8 | 詳細(xì) |
Phenylbutazone Impurity 18 | N,N-DideMethylorphenadrine Hydrochloride | 17752-32-8 | 詳細(xì) |
Phenylbutazone Impurity 19 | (R)-Orphenadrine Citrate | 1202395-79-6 | 詳細(xì) |
Polmacoxib Impurity 11 | 1672668-35-7 | 詳細(xì) | |
Polmacoxib Impurity 12 | 1672668-50-6 | 詳細(xì) | |
Phenylbutazone Impurity 21 | 奧司他韋酸-D3 | 1242184-43-5 | 詳細(xì) |
Phenylbutazone Impurity 22 | 5-(乙酰氨基)-4-氨基-3-(1-乙基丙氧基)-1-環(huán)己烯-1-羧酸 | 1391047-93-0 | 詳細(xì) |
Phenylbutazone Impurity 23 | (3S,4S,5R)-4-(乙酰氨基)-5-氨基-3-(1-乙基丙氧基)-1-環(huán)己烯-1-羧酸乙酯磷酸鹽 | 1035895-89-6 | 詳細(xì) |
Phenylbutazone Impurity 24 | OseltaMivir Acid PotassiuM Salt | 1363339-68-7 | 詳細(xì) |
Phenylbutazone Impurity 25 | 奧司他韋雜質(zhì) | 1415963-60-8 | 詳細(xì) |
Phenylbutazone Impurity 26 | 奧司他韋13CD3 | 1093851-61-6 | 詳細(xì) |
Phenylbutazone Impurity 28 | 2-[4-[(E)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]ethanol | 238089-02-6 | 詳細(xì) |
Phenylbutazone Impurity 31 | 氟氯西林雜質(zhì)7 | 42947-70-6 | 詳細(xì) |
Phenylbutazone Impurity 32 | 氯唑芐星青霉素 | 23736-58-5 | 詳細(xì) |
Osimertinib-13C,d3 | 奧斯替尼-13C,d3 | 2254100-49-5 | 詳細(xì) |
Phenylbutazone Impurity 35 | 3,4-二氟肉桂酸 | 112897-97-9 | 詳細(xì) |
Polmacoxib | 376608-67-2 | 376608-67-2 | 詳細(xì) |
Polmacoxib Impurity 1 | 376608-68-3 | 376608-68-3 | 詳細(xì) |
Polmacoxib Impurity 3 | 替格瑞洛雜質(zhì)8 | 378236-67-0 | 詳細(xì) |
Polmacoxib Impurity 14 | 2055231-72-4 | 詳細(xì) | |
Vecabrutinib Impurity 22 | 脫氮黃素 | 26908-38-3 | 詳細(xì) |
Vecabrutinib Impurity 23 | 四烯甲萘醌雜質(zhì)2 | 70662-30-5 | 詳細(xì) |
Vecabrutinib Impurity 10 | 6-(difluoromethoxy)-1,2,3,4-tetrahydroquinoline | 954264-62-1 | 詳細(xì) |
Vecabrutinib Impurity 11 | 6,7-二甲氧基-3-甲基喹唑啉-2,4(1H,3H)-二酮 | 20197-88-0 | 詳細(xì) |
Vecabrutinib Impurity 12 | 4-苯基-3,4-二氫喹唑啉-2(1H)-酮 | 107289-02-1 | 詳細(xì) |
Vecabrutinib Impurity 13 | 119198-23-1 | 詳細(xì) | |
Vecabrutinib Impurity 14 | 2,4-二羥基-6,7-二乙氧基喹唑啉 | 20197-80-2 | 詳細(xì) |
Vecabrutinib Impurity 15 | 199186-62-4 | 詳細(xì) | |
Vecabrutinib Impurity 16 | 199188-80-2 | 詳細(xì) | |
Vecabrutinib Impurity 17 | 3,4-二氫-3-甲基-2(1H)-喹唑啉酮 | 24365-65-9 | 詳細(xì) |
Vecabrutinib Impurity 18 | 17730-75-5 | 詳細(xì) | |
Vecabrutinib Impurity 21 | 羥甲唑啉雜質(zhì)3 鹽酸鹽 | 205035-03-6 | 詳細(xì) |
Vecabrutinib Impurity 9 | 3-(2-氯乙基)-6,7-二甲氧基-1H-喹唑啉-2,4-二酮 | 110231-26-0 | 詳細(xì) |
Polmacoxib Impurity 15 | 2826252-90-6 | 詳細(xì) | |
Polmacoxib Impurity 16 | 2826252-91-7 | 詳細(xì) | |
Polmacoxib Impurity 17 | 2826252-92-8 | 詳細(xì) | |
Polmacoxib Impurity 18 | 2826252-93-9 | 詳細(xì) | |
Polmacoxib Impurity 19 | 2826252-94-0 | 詳細(xì) | |
Polmacoxib Impurity 20 | 1672668-30-2 | 詳細(xì) | |
Polmacoxib Impurity 21 | 2365402-28-2 | 詳細(xì) | |
Polmacoxib Impurity 22 | 1672668-39-1 | 詳細(xì) | |
Polmacoxib Impurity 23 | 1672668-44-8 | 詳細(xì) | |
Polmacoxib Impurity 24 | 2738682-45-4 | 詳細(xì) | |
Polmacoxib Impurity 25 | 2370102-07-9 | 詳細(xì) | |
Polmacoxib Impurity 26 | 2370015-98-6 | 詳細(xì) | |
Vecabrutinib | 3-(哌啶-4-基)-3,4-二氫喹唑啉-2(1H)-酮 | 79098-75-2 | 詳細(xì) |
Vecabrutinib Impurity 1 | 79098-88-7 | 詳細(xì) | |
Vecabrutinib Impurity 2 | 6-羥基-3,4-二氫喹唑啉-2(1H)-酮 | 948552-89-4 | 詳細(xì) |
Vecabrutinib Impurity 3 | 5-(三氟甲氧基)吲哚酮 | 403853-48-5 | 詳細(xì) |
Vecabrutinib Impurity 4 | 8-(difluoromethoxy)-1,2,3,4-tetrahydroquinoline | 953735-66-5 | 詳細(xì) |
Vecabrutinib Impurity 5 | N-(4-(三氟甲氧基)苯基)哌啶-4-胺 | 681482-48-4 | 詳細(xì) |
Vecabrutinib Impurity 6 | 3-(2-羥基乙基)-6,7-二甲氧基-1H-喹唑啉-2,4-二酮 | 110231-25-9 | 詳細(xì) |
Vecabrutinib Impurity 7 | 3-乙基-6,7-二甲氧基-1H-喹唑啉-2,4-二酮 | 335417-99-7 | 詳細(xì) |
Vibegron Impurity 1 | 四烯甲萘醌雜質(zhì)3 | 55700-10-2 | 詳細(xì) |
Vibegron Impurity 7 | 2370016-14-9 | 詳細(xì) | |
Vibegron Impurity 3 | 1-(N-tryptophan)-1-deoxyfructose | 25020-15-9 | 詳細(xì) |
Vibegron Impurity 2 | MENAQUINONE 4 2,3-EPOXIDE | 72908-86-2 | 詳細(xì) |
Vibegron Impurity 5 | 維貝隆雜質(zhì)5 | 2883232-91-3 | 詳細(xì) |
Vibegron Impurity 11 | 3-丁氧基-4-硝基苯甲酸 | 72101-53-2 | 詳細(xì) |
Vibegron Impurity 9 | 125602-69-9 | 125602-69-9 | 詳細(xì) |
Carenoprazan | 2690342-18-6 | 詳細(xì) | |
Carenoprazan Impurity 2 | 2,2,3,3,4,4,5,5,6,6-decadeuterio-N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexane-1-carboxamide | 1246815-53-1 | 詳細(xì) |
Carenoprazan Impurity 3 | 奈瑪特韋雜質(zhì)34 | 2768834-00-8 | 詳細(xì) |
Carenoprazan Impurity 4 | 奈瑪特韋雜質(zhì)32 | 2768833-99-2 | 詳細(xì) |
Vibegron Impurity 4 | 阿哌沙班雜質(zhì)93 | 40345-06-0 | 詳細(xì) |
Vibegron Impurity 8 | 210095-51-5 | 詳細(xì) | |
Vibegron | 維生素K2雜質(zhì)05 | 110327-29-2 | 詳細(xì) |
Polmacoxib Impurity 4 | PT2977 | 1672668-24-4 | 詳細(xì) |
Rasagiline Impurity 42 | 1030595-43-7 | 詳細(xì) | |
Emorfazone Impurity 6 | 烏諾前列酮 | 120373-36-6 | 詳細(xì) |
Vibegron Impurity 6 | 2370016-04-7 | 詳細(xì) | |
Vecabrutinib Impurity 8 | 3-(3-氯苯基)-6,7-二甲氧基-1H-喹唑啉-2,4-二酮 | 364748-38-9 | 詳細(xì) |
Polmacoxib Impurity 6 | 2007088-15-3 | 詳細(xì) | |
Phenylbutazone Impurity 17 | XMSSICJSZNPVFX-BMSJAHLVSA-N | 1329647-21-3 | 詳細(xì) |
Polmacoxib Impurity 5 | 1672668-51-7 | 詳細(xì) |
產(chǎn)品總數(shù):10335 產(chǎn)品頁碼: | ||||
56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 |
商家暫時(shí)不對外公布